Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 1216 for:    tooth decay

Efficacy of Fluor Protector S in the Prevention in Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03720379
Recruitment Status : Enrolling by invitation
First Posted : October 25, 2018
Last Update Posted : June 27, 2019
Sponsor:
Collaborators:
Ivoclar Vivadent AG
Wroclaw Medical University
Information provided by (Responsible Party):
Medical University of Warsaw

Brief Summary:

Purpose of the study is to evaluate the effectiveness of Fluor Protector S in preventing tooth decay in adolescents and to isolate factors that reduce its effectiveness.

In this study, half of the randomly assigned participants will received fluoride varnish (Fluor Protector S) and will be considered an intervention group. The other half will undergo placebo application.


Condition or disease Intervention/treatment Phase
Dental Caries Fluor Device: Fluor Protector S Device: Placebo Not Applicable

Detailed Description:

Evidence from 6 systematic reviews involving 200 trials and more than 80,000 participants further supports the effectiveness of fluoride varnishes, applied professionally 2-4 times a year, for preventing dental caries. Additionally, the simultaneous use of fluoride varnishes with fluoride toothpaste appears to significantly enhance the caries-inhibiting effect compared with the use of fluoride toothpaste alone. The relative benefit of fluoride varnishes application seems to occur irrespective of baseline caries risk, baseline caries severity, background exposure to fluorides and application features such as prior prophylaxis, concentration of fluoride or frequency of application.

To determine the sample size, the results of epidemiological studies conducted in the framework of the health monitoring of the Polish population in 2015 in the group of people aged 15 years (dmf = 5.75) and in 2016 in the group of people aged 12 years (dmf = 3) 0.7 as annual growth of caries, and literature data on the effectiveness of fluoride varnish in the prevention of permanent tooth decay in the general population at 43% (a reduction of about 0.3% per year in dmf, Standard Deviation = 0.8) and was considered achievable in the case Apply Fluor Protector S at 3 months intervals in the high risk group of caries. Size of the study group with such assumptions (α = 0,05, power = 80%, mean reduction of dmf: 0,3, Standard Deviation = 0,8 ; t test for comparison of two groups) - Minimum 84 patients [70 patients+ 20% (dropped out), in both groups].

Participants will be allocated to the "test" and to the "control" group, respectively, by computer-generated randomly permuted blocks using R package in statistical software..

  • The children will be examined and re-examined clinically by the same examiners.
  • Statistical analyses will be performed using statistical software, the level of significance was set at 0.05. Intra-examiner reliability was assessed by kappa statistics.
  • To compare average values between two independent groups U Mann-Whitney test will be used (for e.g. to compare experimental group with the control one); Wilcoxon signed-rank test will be used for paired samples (for e.g. to compare first measurement with final measurement for experimental group). Comparison of fractions will be conducted using Pearson's chi-square test of independence and Z test. The 95% confidence intervals will be calculated on the basis of normal approximation.

Purpose of the study is to evaluate the effectiveness of Fluor Protector S in preventing tooth decay in adolescents and to isolate factors that reduce its effectiveness.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 168 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

We plan to include 168 subjects in this study.

  1. Dental examination Qualified for the study will receive oral and written information on the causative factors of dental caries, hygienic and dietary recommendations.
  2. Oral hygiene instruction will be provided.
  3. Caries risk assesment
  4. Application Fluor Protector S or Placebo

Dental examination will be performed before the intervention (preliminary), after 6 months and after 12 months. Dental exams will include an interview, a physical examination , radiological examination (bite- wing x-ray images) and Diagnodent assessment.

The applications of Fluor Protector S (intervention A) or placebo (intervention B) will be performed every three months during one year.

Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description: All participants,Care Providers, Investigators and Outcomes Assessor will be aware of the current subject's allocation and will be unconscious which product is fluoride varnish and which placebo. participants assigned to intervention(s) based on a protocol Patients will be distributed between Group A (Fluor Protector S) and group B (placebo) according to allocation for 2 types of intervention and blindness (codes for the type of intervention A and B will be assigned to patient numbers according to the reporting order and placed in opaque envelopes).
Primary Purpose: Prevention
Official Title: Efficacy of Fluor Protector S in the Prevention of Tooth Decay in Adolescents
Actual Study Start Date : October 19, 2018
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : May 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tooth Decay
Drug Information available for: Fluoride

Arm Intervention/treatment
Active Comparator: Fluoride Varnish - Fluor PROTECTOR S

Fluor Protector S - manufacturer: Ivoclar Vivadent Composition: ethanol, water, polymer, saccharin, mint flavor, 1.5% ammonium fluoride (7700 ppm fluoride), additional ingredients

APPLICATION OF Fluor Protector S will be performed AT BASELINE, after 3,6 months (control 1) and after 9 and 12 months (control 2). Preliminary(AT BASELINE) and control dental exams after 12 months will include an interview and a physical examination, radiological and Diagnodent examination, a 6 months follow-up -a physical examination, Diagnodent examination and interview.

Device: Fluor Protector S
. All of the elements of a clinical trial and the varnish applications will be performed every three-month during one year: Changes in The Simplified Oral Hygiene Index (OHl-S), white spot carious lesion discovered at the initial assessment as invisible, visible and inactive, active, cavities), dmft and dmfs and their components, bite-wings and Diagnodent assessment will be scored at follow-up examinations.

Placebo Comparator: PLACEBO

- Placebo - manufacturer: Ivoclar Vivadent Composition: ethanol, water, polymer, saccharin, mint flavor.

APPLICATION OF PLACEBO will be performed AT BASELINE, after 3,6 months (control 1) and after 9 AND 12 months (control 2). Preliminary(AT BASELINE) and control dental exams after 12 months will include an interview and a physical examination, radiological and Diagnodent examination, a 6 months follow-up -a physical examination, Diagnodent examination and interview.

Device: Placebo
All of the elements of a clinical trial and the placebo applications will be performed every three-month during one year: Changes in The Simplified Oral Hygiene Index (OHl-S), white spot carious lesion discovered at the initial assessment as invisible, visible and inactive, active, cavities), dmft and dmfs and their components, bite-wings and Diagnodent assessment will be scored at follow-up examinations.




Primary Outcome Measures :
  1. Occurrence and intensity of dental caries [ Time Frame: 12 months ]

    The decrease of caries, which means a lower caries occurrence and intensity (lower caries index dmft/dmfs) when comparing to the placebo group.

    Diagnodent assessment scale similar at baseline and at the end of the study. The same number of teeth/surfaces with no caries in the fluoride varnish group when comparing to the placebo group, according to scale:

    0-14 No caries 15-20 Enamel caries 21-99 Dentinal caries

    In the study, bite-wing images are planned at 12 months intervals. The scale will be used to evaluate:

    E1 - carious lesion including <1/2 enamel, E2 - carious lesion including> 1/2 enamel, D1 - tooth decay in dentin, not exceeding 1/3 of dentin, D2 - caries in the middle 1/3 of dentin, D3 carious lesion > 2/3 of dentin. Codes E1 and E2 will be recorded as pre-cavity, codes ≥ D1 as cavity. Primary outcome is no signs of caries during radiological examination in fluoride varnish group when comparing to the placebo group.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age> 12 ≤ 19 years
  • All permanent teeth (except the third molar teeth)
  • Restored caries lesions
  • Teeth with International Caries Detection and Assessment System II score 0, 1, or 2
  • Agreement of parents / legal guardians and patients to participate in the study

Exclusion Criteria:

  • Planned change of residence during the year
  • Chronic illness or medication that increases the risk of tooth decay
  • Orthodontic treatment
  • Caries lesions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03720379


Locations
Layout table for location information
Poland
Dorota Olczak-Kowalczyk
Warsaw, Warsaw, 18 Miodowa Saint, Poland, 00-246
Sponsors and Collaborators
Medical University of Warsaw
Ivoclar Vivadent AG
Wroclaw Medical University
Investigators
Layout table for investigator information
Study Director: Dorota Olczak Kowalczyk, PROFESSOR Medical University of Warsaw

Publications:

Layout table for additonal information
Responsible Party: Medical University of Warsaw
ClinicalTrials.gov Identifier: NCT03720379     History of Changes
Other Study ID Numbers: KB/226/2017
First Posted: October 25, 2018    Key Record Dates
Last Update Posted: June 27, 2019
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Medical University of Warsaw:
fluoride varnish
dental caries
ADOLESCENTS

Additional relevant MeSH terms:
Layout table for MeSH terms
Dental Caries
Tooth Demineralization
Tooth Diseases
Stomatognathic Diseases
Fluorides
Fluorides, Topical
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs